Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy clinical trials

Explore recruiting paresthesia numbness tingling secondary to chemotherapy induced neuropathy clinical trials.

Recruiting paresthesia numbness tingling secondary to chemotherapy induced neuropathy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effectiveness and cost-effectiveness of ozone treatment in patients with paresthesia (numbness, tingling) secondary to chemotherapy-induced peripheral neuropathy. Randomized, triple-blind clinical trial (OzoParQT).

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy trials by city

Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Toronto Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Vancouver Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Montreal Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Calgary Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Edmonton Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Ottawa Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Winnipeg Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Quebec City Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Hamilton Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Kitchener Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in London Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Halifax Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in New York Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Los Angeles Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Chicago Paresthesia Numbness Tingling Secondary To Chemotherapy Induced Neuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease